Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Voyager Acquisition Corporation VACH

Alternate Symbol(s):  VACHU | VACHW

Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. The company was incorporated in 2023 and is based in Brooklyn, New York. see more

Current News (NDAQ:VACH)

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-PBBK, VACH, LCTC, and SMLR

GlobeNewswire November 7, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRTAF, LCTC, VACH, and EFIN

PR Newswire October 21, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Voyager Acquisition Corp. (NASDAQ: VACH)

GlobeNewswire July 17, 2025

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

GlobeNewswire July 17, 2025

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

GlobeNewswire May 29, 2025

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

GlobeNewswire May 5, 2025

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

GlobeNewswire April 23, 2025

Voyager Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about September 30, 2024

GlobeNewswire September 26, 2024

Voyager Acquisition Corp. Announces Closing of $253,000,000 Initial Public Offering

GlobeNewswire August 12, 2024

Opinion & Analysis (NDAQ:VACH)

No current opinion is available.

Bullboard Posts (NDAQ:VACH)

Podcasts